BIOXCEL THERAPEUTICS INC (BTAI)

US09075P1057 - Common Stock

0.3567  -0.03 (-7.06%)

Premarket: 0.362 +0.01 (+1.49%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
2.28M1.38M380.00K0.000.00
Cost Of Goods
2.03M1.26M20.00KN/AN/A
Gross Profit
250.00K120.00K360.00KN/AN/A
Operating Expenses
74.47M167.74M160.00M106.94M82.30M
Research and Development
34.47M84.33M91.24M52.71M58.00M
Selling, General, and Administrative Expenses
40.00M83.41M68.76M54.23M24.30M
Operating Income
-74.22M-167.62M-159.65M-106.94M-82.30M
Interest Income/Expense
-11.35M-7.67M-5.69M0.00130.00K
Other Income/Expense
16.98M394.00K-430.00KN/AN/A
Non Recurring Items
N/A-4.16MN/AN/AN/A
Income Before Taxes
-71.00M-179.05M-165.76M-106.93M-82.17M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-71.00M-179.05M-165.76M-106.93M-82.17M
EBITDA
-73.91M-167.30M-159.32M-106.64M-82.11M
 
Per Share Data
EPS Diluted Total Ops
-2.15-6.15-5.92-4.05-3.79
Non GAAP EPS
-2.16-6.15-5.91-4.08-3.79
 
Statistics
Gross Profit Margin
10.98%8.70%94.74%N/AN/A
Profit Margin
-3119.33%-12974.86%-43621.05%N/AN/A
Operating Profit Margin
-3260.90%-12146.30%-42013.16%N/AN/A

All data in USD

Charts